Postmastectomy Radiation Therapy Based on Pathologic Nodal Status in Clinical Node-Positive Stage II to III Breast Cancer Treated with Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Postmastectomy Radiation Therapy Based on Pathologic Nodal Status in Clinical Node-Positive Stage II to III Breast Cancer Treated with Neoadjuvant Chemotherapy

Published:2020-11 Issue:4 Volume:108 Page:1030-1039
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Huang Zhou,Zhu Li,Huang Xiao-Bo,Tang Yu,Rong Qing-Lin,Shi Mei,Wang Wei-Hu,Tie Jian,Shen Liang-Fang,Chen Jia-Yi,Zhang Jun,Wu Hong-Fen,Cheng Jing,Liu Min,Tan Yu-Ting,Ma Chang-Ying,Wang Shu-Lian,Li Ye-Xiong

Funder

National Key Projects of Research and Development of China

Capital Characteristic Clinic Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference27 articles.

1. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States;Mougalian;Cancer,2015

2. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial;Overgaard;N Engl J Med,1997

3. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer;Ragaz;N Engl J Med,1997